Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yin-Xiao Du"'
Autor:
Tao Wang, Si-Qin Wang, Yin-Xiao Du, Dan-Dan Sun, Chang Liu, Shuang Liu, Ying-Ying Sun, Hai-Long Wang, Chun-Sheng Zhang, Hai-Long Liu, Lei Jin, Xiao-Ping Chen
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Targeting CD47/SIRPα axis has emerged as a promising strategy in cancer immunotherapy. Despite the encouraging clinical efficacy observed in hematologic malignancies through CD47-SIRPα blockade, there are safety concerns related
Externí odkaz:
https://doaj.org/article/a1c03c450dda44e1a36c6d58ab761d99
Autor:
Lihan Zhao, Wen-Jian Xie, Yin-Xiao Du, Yi-Xuan Xia, Kang-Lun Liu, Chuen Fai Ku, Zihao Ou, Ming-Zhong Wang, Hong-Jie Zhang
Publikováno v:
Molecules, Vol 28, Iss 16, p 6165 (2023)
The dichloromethane extract of the roots of Bridelia balansae Tutcher (Phyllanthaceae) was found to show potential anticancer activity against HCT116 colorectal cancer cell. Our bioassay-guided phytochemical investigation of the roots of B. balansae
Externí odkaz:
https://doaj.org/article/74470cbe057c4a2cb118360621fe9068
Autor:
Yan‐Ling Liu, Xiao‐Lei Hu, Pei‐Yuan Song, He Li, Mu‐Peng Li, Yin‐Xiao Du, Mo‐Yun Li, Qi‐Lin Ma, Li‐Ming Peng, Ming‐Yu Song, Xiao‐Ping Chen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 21 (2021)
Background Dual antiplatelet therapy based on aspirin and P2Y12 receptor antagonists such as clopidogrel is currently the primary treatment for coronary artery disease (CAD). However, a percentage of patients exhibit clopidogrel resistance, in which
Externí odkaz:
https://doaj.org/article/b0140c75f1a84768a0e19bdee1ec7949
Autor:
Xiao-Qing Yuan, Peng Chen, Yin-Xiao Du, Ke-Wei Zhu, Dao-Yu Zhang, Han Yan, Han Liu, Yan-Ling Liu, Shan Cao, Gan Zhou, Hui Zeng, Shu-Ping Chen, Xie-Lan Zhao, Jing Yang, Wen-Jing Zeng, Xiao-Ping Chen
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background The influence of DNMT3A R882 mutations on adult acute myeloid leukemia (AML) prognosis is still controversial presently. The influence of R882 allele ratio on drug response and prognosis of AML is unknown yet. Besides, it is obscu
Externí odkaz:
https://doaj.org/article/3526266a67a24d8897cd1de1478dac51
Publikováno v:
Pharmacogenetics & Genomics; Aug2024, Vol. 34 Issue 6, p191-198, 8p
Publikováno v:
Nutrients; Volume 15; Issue 13; Pages: 3006
Management of obesity has become a prevalent strategy for preventing the diseases closely integrated with excess body weight such as diabetes over the last half century. Searching for therapeutic agents acting on oxidative stress, adipogenesis and in
Publikováno v:
International Journal of Molecular Sciences. 24:7310
Autophagy is a highly conserved intracellular degradation pathway by which misfolded proteins or damaged organelles are delivered in a double-membrane vacuolar vesicle and finally degraded by lysosomes. The risk of colorectal cancer (CRC) is high, an
Autor:
Qi-Lin Ma, He-Li, Yin-Xiao Du, Kong-Xiang Zhu, Xiao-Ping Chen, Pei-Yuan Song, Li-Ming Peng, Mu-Peng Li
Publikováno v:
European Journal of Clinical Pharmacology. 77:359-368
Dual antiplatelet therapy with aspirin and clopidogrel is commonly used for coronary artery disease (CAD) patients undergoing percutaneous coronary intervention to prevent stent thrombosis and ischemic events. However, some patients show high on-trea
Autor:
Li‐Ming Peng, He Li, Mu‐Peng Li, Qi‐Lin Ma, Xiao‐Ping Chen, Xiao‐Lei Hu, Yin‐Xiao Du, Mo‐Yun Li, Ming‐Yu Song, Pei‐Yuan Song, Yan‐Ling Liu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 21 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 21 (2021)
Background Dual antiplatelet therapy based on aspirin and P2Y12 receptor antagonists such as clopidogrel is currently the primary treatment for coronary artery disease (CAD). However, a percentage of patients exhibit clopidogrel resistance, in which
Autor:
Xiao-Ping Chen, Yin Xiao Du
Publikováno v:
Clinical Pharmacology & Therapeutics
An outbreak of 2019-nCoV infection has spread across the world. No specific antiviral drugs have been approved for the treatment of COVID-2019. In addition to the recommended antiviral drugs, such as interferon-ɑ, lopinavir/ritonavir, ribavirin, and